Performance of omalizumab in patients with mast cell–mediated angioedema with and without wheals
Publication date
2026-06
Authors
van der Kamp, Sara
Soegiharto, Reineke
Sørensen, Jennifer Astrup
Demir, Ferhan Bulut
Porras, Nasser Mohammad
Matsuo, Yoshimi
Kiefer, Lea
Knulst, A C
Maurer, Marcus
Ritchie, Carla
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by
Abstract
Keywords
Immunology and Allergy
Citation
van der Kamp, S, Soegiharto, R, Sørensen, J A, Demir, F B, Porras, N M, Matsuo, Y, Kiefer, L, Knulst, A C, Maurer, M, Ritchie, C, Rudenko, M, Kocatürk, E, Criado, R F J, Gregoriou, S, Bobylev, T, Kleinheinz, A, Takahagi, S, Hide, M, Giménez-Arnau, A M, Salman, A, Kara, R O, Dikicier, B S, van Doorn, M B A, Thomsen, S F, van den Reek, J M P A & Röckmann, H 2026, 'Performance of omalizumab in patients with mast cell–mediated angioedema with and without wheals', Journal of Allergy and Clinical Immunology: In Practice, vol. 14, no. 6, pp. 1457-1460.e1. https://doi.org/10.1016/j.jaip.2026.03.004